New Novartis Data Reveals Cosentyx® is Superior to Stelara® in Psoriasis Patients

New Novartis Data Reveals Cosentyx® is Superior to Stelara® in Psoriasis Patients

This is an important milestone in the treatment of psoriasis, a skin disease with significant physical and emotional impact on a patient's life. I am encouraged by the data from the CLEAR study as it validates Cosentyx® as an effective treatment option

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.